Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Jagadeesh Dhamodharan"'
Autor:
Sumeet Kumar Singla, Arunachalam Muthuraman, Diksha Sahai, Naveen Mangal, Jagadeesh Dhamodharan
Publikováno v:
Frontiers in Bioscience-Elite, Vol 13, Iss 1, Pp 158-184 (2020)
Transdermal drug-delivery systems (TDDS) offer an attractive alternative to the oral route for delivery of biotherapeutics. Technological advancements in the past few decades have revolutionized the fabrication of micro-structured devices including c
Externí odkaz:
https://doaj.org/article/5933bd97e75d4616bcc61757eed03c42
Publikováno v:
Molecules, Vol 27, Iss 16, p 5182 (2022)
Alzheimer’s disease (AD) is one of the major neurodegenerative disorders, and its incidence increases globally every year. Currently, available AD drugs symptomatically treat AD with multiple adverse effects. Gefitinib (GE) is an epidermal growth f
Externí odkaz:
https://doaj.org/article/1c14904eaea84cc59438f3137a965a37
Autor:
Jagadeesh Dhamodharan, Julie Christy Amalraj, M. Sathish Kumar, Mukilan Ramadoss, K. Prabhu, M. Kavimani, S. Angelie Jessica
Publikováno v:
Journal of Complementary and Alternative Medical Research. :16-24
Diabetes is a common non-transmittable disease in the world today. It is the fourth leading cause of mortality in most developed nations and there is significant proof that it is widespread in many developing and newly developed nations. Diabetes pat
Autor:
Arunachalam Muthuraman, Muthusamy Ramesh, Aswinprakash Subramanian, Jagadeesh Dhamodharan, Lim Khian Giap
Publikováno v:
Coronaviruses. 3
Abstract: COVID-19 is a respiratory infection caused by a newer strain of coronavirus known as SARSCoV-2. The major problem of COVID-19 infections is the ARDS, followed by respiratory failure, organ failure, and even death with multiple organ dysfunc
Background:Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that accounts for about 60-80% of dementia cases globally.Currently used AD drugs provide only symptomatic management with lots of adverse effects. A drug with potentia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b02ae0de7e6249e47ca055245041e392
Autor:
Kasi Marimuthu, Sivachandran Parimannan, Christopher Simon, Manickam Ravichandran, Arulmoli Krishnan, Heera Rajandas, Nur Afiqah Mohamad, Jagadeesh Dhamodharan, Premasangery Kathivaloo, Bharathi Sengodan, Quan Fu Gan, Vasanth Raj Palanimuthu
Publikováno v:
International Journal of Molecular Sciences
Volume 20
Issue 3
International Journal of Molecular Sciences, Vol 20, Iss 3, p 568 (2019)
Simon, C, Gan, Q F, Kathivaloo, P, Mohamad, N A, Dhamodharan, J, Krishnan, A, Sengodan, B, Palanimuthu, V R, Marimuthu, K, Rajandas, H, Ravichandran, M & Parimannan, S 2019, ' Deciduous DPSCs Ameliorate MPTP-Mediated Neurotoxicity, Sensorimotor Coordination and Olfactory Function in Parkinsonian Mice ', International journal of molecular sciences, vol. 20, no. 3, 568 . https://doi.org/10.3390/ijms20030568
Volume 20
Issue 3
International Journal of Molecular Sciences, Vol 20, Iss 3, p 568 (2019)
Simon, C, Gan, Q F, Kathivaloo, P, Mohamad, N A, Dhamodharan, J, Krishnan, A, Sengodan, B, Palanimuthu, V R, Marimuthu, K, Rajandas, H, Ravichandran, M & Parimannan, S 2019, ' Deciduous DPSCs Ameliorate MPTP-Mediated Neurotoxicity, Sensorimotor Coordination and Olfactory Function in Parkinsonian Mice ', International journal of molecular sciences, vol. 20, no. 3, 568 . https://doi.org/10.3390/ijms20030568
Parkinson&rsquo
s disease (PD) is a neurodegenerative disorder defined by progressive deterioration of dopaminergic neurons in the substantia nigra pars compacta (SNpc). Dental pulp stem cells (DPSCs) have been proposed to replace the degenerate
s disease (PD) is a neurodegenerative disorder defined by progressive deterioration of dopaminergic neurons in the substantia nigra pars compacta (SNpc). Dental pulp stem cells (DPSCs) have been proposed to replace the degenerate
Autor:
Arunachalam Muthuraman, Diksha Sahai, Naveen Mangal, Jagadeesh Dhamodharan, Sumeet Kumar Singla
Publikováno v:
Scopus-Elsevier
Transdermal drug-delivery systems (TDDS) offer an attractive alternative to the oral route for delivery of biotherapeutics. Technological advancements in the past few decades have revolutionized the fabrication of micro-structured devices including c
Autor:
Shaikh, Sohrab A.1 (AUTHOR), Muthuraman, Arunachalam1 (AUTHOR) arunachalammu@gmail.com
Publikováno v:
Pharmaceuticals (14248247). Jun2023, Vol. 16 Issue 6, p828. 12p.
Autor:
Shaikh, Sohrab A.1 (AUTHOR), Varatharajan, Rajavel1 (AUTHOR), Muthuraman, Arunachalam1 (AUTHOR) arunachalammu@gmail.com
Publikováno v:
International Journal of Molecular Sciences. Nov2022, Vol. 23 Issue 21, p13531. 19p.
Autor:
Dhamodharan, Jagadeesh1,2 (AUTHOR), Sekhar, Ganthimathy2 (AUTHOR), Muthuraman, Arunachalam3 (AUTHOR) arunachalammu@gmail.com
Publikováno v:
Molecules. Aug2022, Vol. 27 Issue 16, p5182-5182. 13p.